PomegraElevance Health Stock Slips 1.4% Despite Earnings Beat and Raised Outlook
Why did Elevance Health stock fall after an earnings beat?
Elevance Health (ELV) stock fell 1.4% to $434.13 on Wednesday despite an earnings beat, as $1.85 of its $6.99 per-share profit came from investment gains that may not repeat.
Key numbers
| Adjusted EPS (Q3) | $6.99+16% YoY; $4.70 expected |
|---|---|
| Operating revenue | $50.4B+0.7% YoY |
| 2026 adjusted EPS floor | ≥ $29.00from ≥ $27.00 |
| Benefit expense ratio | 90.6%-0.7 pts YoY |
| Non-operating gain | $1.85/shareincluded in $6.99 |
| Medical members | 44.9M-487,000 YoY |
What happened
Elevance Health (ELV) stock fell 1.4% to $434.13 on Wednesday despite an earnings beat, as $1.85 of its $6.99 per-share profit came from investment gains that may not repeat. Adjusted earnings (profit with one-off items removed) beat the $4.70 analysts expected, on sales of $50.4 billion, up 0.7% from a year ago. Medical bills took a smaller share of premiums, 90.6%, down 0.7 points from a year earlier. Elevance also raised its 2026 profit floor (the least it expects to earn) to at least $29 a share, from at least $27.
Why it matters
Elevance Health is one of the largest U.S. health insurers, so how much it pays out for patients' care is a signal for the whole industry. Medical bills are taking less of the premiums it collects, especially in Medicare Advantage (government-backed plans for older adults) and Obamacare plans. But $1.85 of the $6.99 came from gains on private investments, and it has 487,000 fewer members than a year ago, so the picture is mixed.
Who this affects
- MarketmixedMedium impact
- Investors liked the beat, but shares still ended lower.
- CompanybullishHigh impact
- Shareholders get a higher 2026 profit target and 2027 baseline.
- CompetitorsneutralLow impact
- Rival insurers slipped less than 1% on Wednesday.
- IndustryneutralMedium impact
- Easing medical costs would help insurer profits if they last.
Elevance Health vs UnitedHealth, Centene, Humana
How we got here
Quarter ends with 44.9 million medical members, down 487,000 from a year earlier.
Elevance reports Q3 adjusted EPS of $6.99 and raises 2026 floor to at least $29.
Shares rise about 1.7% early, then close down 1.37% at $434.13.
What to watch
- Centene reports Q3 results, a read on whether rivals also see lower medical costs.2026-10-27
- Cigna reports Q3 results, another gauge of insurer cost trends.2026-11-05
- Elevance's 2027 target: at least 12% EPS growth from a baseline of at least $26.75.Q4 2026
Educational content only. Not investment advice.
More briefsAll briefs →
CATL Stock Falls 12% After Q3 Earnings Miss
CATL (300750.SZ) profit grew just 14.5% versus 41% expected, as a new battery tax squeezed margins.
Lockheed Martin, Blackstone Earnings Due Thursday; $7.52 EPS Expected
Lockheed Martin (LMT) is set to report $20.5B in sales, alongside Blackstone, Comcast, Honeywell and P&G
Berkshire Hathaway Stock Hits Record $539.82 After CEO Change
Berkshire (BRK.B) gained 7% in three weeks while chip stocks fell 15%, as investors moved past Buffett.